Print Friendly Page
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
The purpose of this study is to compare any good or bad effects of adding triapine to the usual cisplatin chemotherapy and radiation therapy, compared to using cisplatin chemotherapy and radiation therapy alone. The addition of triapine to the usual chemotherapy and radiation therapy could shrink your tumor and increase the length of time till the cancer returns, but it could also cause side effects. This study will allow the researchers to know whether this different approach is better, the same, or worse than the usual approach.
You will receive the cisplatin chemotherapy and radiation therapy or triapine given with cisplatin chemotherapy and radiation therapy for up to eight weeks.
A computer will by chance assign you to treatment groups in the study. This is called randomization. Group 1 will get the usual cisplatin chemotherapy and radiation therapy used for this type of cancer. Group 2 will get the usual cisplatin chemotherapy and radiation therapy used for this type of cancer plus an investigational study drug called triapine three times per week. Triapine will need to be given through a tube inserted into a vein near your arm (IV) that allows the drug to be given directly into the vein each time you receive the drug.
- New, untreated histologic diagnosis of state IB2, II, IIIB or IVA squamous, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix or stage II-IVA squamous, adenocarcinoma, or adenosquamous carcinoma of the vagina for which cervical treatment is not possible
- Uncontrolled diabetes mellitus not allowed
- Known brain metastases not allowed
- Known HIV syndrome not allowed
Applicable Disease Sites
Cytotoxic Chemotherapy; Other; Radiotherapy
cis-diamminedichloroplatinum (cisplatin); cisplatin; platinol (cisplatin); platinum (cisplatin); triapine
UW Hospital and Clinics